Open Label Continuation Study in Moderate to Severe Psoriasis

Completed · Phase 3

Conditions studied: Moderate to Severe Plaque Psoriasis

In brief

The purpose of this study is to evaluate long term safety, efficacy and tolerability of ABT-874 in adults with moderate to severe psoriasis.

Key facts

Study ID

NCT00626002

Run by

AbbVie (prior sponsor, Abbott)

People needed

2301

Starts

2008-02-01

Expected to finish

2011-10-01

Last updated by the study team

2013-01-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Having participated in a preceding ABT-874 clinical trial for ABT-874
• Subject has a clinical diagnosis of moderate to severe plaque psoriasis

You may not qualify if…

• Subjects who prematurely discontinued in any preceding psoriasis study with ABT-874 other than protocol-required discontinuation

Where it is running

• Site Reference ID/Investigator# 8438 — Birmingham, Alabama, United States
• Site Reference ID/Investigator# 7522 — Huntsville, Alabama, United States
• Site Reference ID/Investigator# 7774 — Scottsdale, Arizona, United States
• Site Reference ID/Investigator# 7435 — Tucson, Arizona, United States
• Site Reference ID/Investigator# 7933 — Little Rock, Arkansas, United States
• Site Reference ID/Investigator# 7234 — Bakersfield, California, United States
• Site Reference ID/Investigator# 8249 — Fresno, California, United States
• Site Reference ID/Investigator# 7332 — Irvine, California, United States
• Site Reference ID/Investigator# 7239 — Los Angeles, California, United States
• Site Reference ID/Investigator# 8390 — Oceanside, California, United States
• Site Reference ID/Investigator# 7503 — San Diego, California, United States
• Site Reference ID/Investigator# 7520 — San Diego, California, United States
• Site Reference ID/Investigator# 7010 — San Diego, California, United States
• Site Reference ID/Investigator# 10962 — San Francisco, California, United States
• Site Reference ID/Investigator# 7334 — Santa Monica, California, United States
• Site Reference ID/Investigator# 7793 — Vallejo, California, United States
• Site Reference ID/Investigator# 7929 — Denver, Colorado, United States
• Site Reference ID/Investigator# 7436 — Longmont, Colorado, United States
• Site Reference ID/Investigator# 7521 — New Haven, Connecticut, United States
• Site Reference ID/Investigator# 7653 — Doral, Florida, United States
• Site Reference ID/Investigator# 8341 — Jacksonville, Florida, United States
• Site Reference ID/Investigator# 7716 — Miami, Florida, United States
• Site Reference ID/Investigator# 7657 — Miami, Florida, United States
• Site Reference ID/Investigator# 10841 — South Miami, Florida, United States
• Site Reference ID/Investigator# 7496 — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.